Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours

Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807 · see citing works

The National Comprehensive Cancer Network

McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+ · Cited by 16,760 · see citing works

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella‐Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,703 · see citing works

The 2021 WHO classification of tumors of the central nervous system: a summary

Louis, D. N., Perry, A., Wesseling, P., Brat, D. J., Cree, I. A., Figarella-Branger, D., Hawkins, C., Ng, H. K., Pfister, S. M., Reifenberger, G., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab106 · Cited by 12,273 · see citing works

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010

Ostrom, Q. T., Gittleman, H. R., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C. A., & Barnholtz‐Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 12,049 · see citing works

<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma

Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405 · see citing works

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · see citing works

<i>IDH1</i> and <i>IDH2</i> Mutations in Gliomas

Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847 · see citing works

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

The Cancer Genome Atlas Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402121 · Cited by 3,148 · see citing works

DNA methylation-based classification of central nervous system tumours

Capper, D., Jones, D., Sill, M., Hovestadt, V., Schrimpf, D., Sturm, D., Koelsche, C., Sahm, F., Chávez, L., Reuß, D., et al. (2018) · Nature · doi:10.1038/nature26000 · Cited by 3,046 · see citing works

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018

Ostrom, Q. T., Cioffi, G., Waite, K. A., Kruchko, C., & Barnholtz‐Sloan, J. S. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab200 · Cited by 2,661 · see citing works

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial

Stupp, R., Taillibert, S., Kanner, A., Read, W., Steinberg, D. M., Lhermitte, B., Toms, S., Idbaih, A., Ahluwalia, M. S., Fink, K., et al. (2017) · JAMA · doi:10.1001/jama.2017.18718 · Cited by 2,644 · see citing works

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631 · see citing works

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

Weller, M., van den Bent, M., Preusser, M., Le Rhun, E., Tonn, J. C., Minniti, G., Bendszus, M., Balana, C., Chinot, O., Dirven, L., et al. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00447-z · Cited by 2,048 · see citing works

Glioma Groups Based on 1p/19q, IDH , and TERT Promoter Mutations in Tumors

Eckel‐Passow, J. E., Lachance, D. H., Molinaro, A. M., Walsh, K. M., Decker, P. A., Sicotte, H., Pekmezci, M., Rice, T., Kosel, M., Smirnov, I. V., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1407279 · Cited by 1,981 · see citing works

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013–2017

Ostrom, Q. T., Patil, N. T., Cioffi, G., Waite, K. A., Kruchko, C., & Barnholtz‐Sloan, J. S. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa200 · Cited by 1,972 · see citing works

Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma

Sturm, D., Witt, H., Hovestadt, V., Khuong-Quang, D.-A., Jones, D. T. W., Konermann, C., Pfaff, E., Tönjes, M., Sill, M., Bender, S., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.024 · Cited by 1,828 · see citing works

The New WHO Classification of Brain Tumours

Kleihues, P., Burger, P. C., & SCHEITHAUER, B. W. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00752.x · Cited by 1,599 · see citing works

Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups

Pajtler, K. W., Witt, H., Sill, M., Jones, D., Hovestadt, V., Kratochwil, F., Wani, K., Tatevossian, R., Punchihewa, C., Johann, P. D., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.002 · Cited by 1,226 · see citing works

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

van den Bent, M. J., Brandes, A. A., TAPHOORN, M. J. B., Kros, J. M., Kouwenhoven, M. C. M., Delattre, J., Bernsen, H. J. J. A., Frénay, M., Tijssen, C. C., Grisold, W., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.2229 · Cited by 1,220 · see citing works

Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402

Cairncross, G. J., Wang, M., Shaw, E., Jenkins, R. B., Brachman, D. G., Buckner, J. C., Fink, K., Souhami, L., Laperrière, N., Curran, W., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.2674 · Cited by 1,152 · see citing works

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

Buckner, J. C., Shaw, E. G., Pugh, S. L., Chakravarti, A., Gilbert, M. R., Barger, G. R., Coons, S., Ricci, P., Bullard, D., Brown, P. D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1500925 · Cited by 1,064 · see citing works

K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas

Khuong-Quang, D.-A., Buczkowicz, P., Rakopoulos, P., Liu, X.-Y., Fontebasso, A. M., Bouffet, E., Bartels, U., Albrecht, S., Schwartzentruber, J., Letourneau, L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0998-0 · Cited by 1,028 · see citing works

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

Schindler, G., Capper, D., Meyer, J., Janzarik, W. G., Omran, H., Herold‐Mende, C. C., Schmieder, K., Wesseling, P., Mawrin, C., Hasselblatt, M., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0802-6 · Cited by 1,027 · see citing works

Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma

Packer, R. J., Gajjar, A. J., Vézina, G., Rorke-Adams, L. B., Burger, P. C., Robertson, P. L., Bayer, L. A., Lafond, D. A., Donahue, B. R., Marymont, M. H., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4980 · Cited by 985 · see citing works

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

Sturm, D., Orr, B. A., Toprak, U. H., Hovestadt, V., Jones, D., Capper, D., Sill, M., Buchhalter, I., Northcott, P. A., Irina, L., et al. (2016) · Cell · doi:10.1016/j.cell.2016.01.015 · Cited by 979 · see citing works

cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

Brat, D. J., Aldape, K., Colman, H., Holland, E. C., Louis, D. N., Jenkins, R. B., Kleinschmidt-DeMasters, B. K., Perry, A., Reifenberger, G., Stupp, R., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1913-0 · Cited by 904 · see citing works

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

Sahm, F., Schrimpf, D., Stichel, D., Jones, D., Hielscher, T., Schefzyk, S., Okonechnikov, K., Koelsche, C., Reuß, D., Capper, D., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30155-9 · Cited by 863 · see citing works

Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)

Drilon, A. E. D. C., Siena, S., Ou, S. I., Patel, M. R., Ahn, M., Lee, J., Bauer, T. M., Farago, A. F., Wheler, J. J., Liu, S. V., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1237 · Cited by 827 · see citing works

A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma

Jenkins, R. B., Blair, H. E., Ballman, K. V., Giannini, C., Arusell, R. M., Law, M., Flynn, H. C., Passe, S. M., Felten, S. J., Brown, P. D., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1796 · Cited by 762 · see citing works

Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone

Rutkowski, S., Bode, U., Deinlein, F., Ottensmeier, H., Warmuth‐Metz, M., Soerensen, N., Graf, N. M., Emser, A., Pietsch, T., Wolff, J. E. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042176 · Cited by 748 · see citing works

Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features

Kool, M., Köster, J., Bunt, J., Hasselt, N. E., Lakeman, A., Sluis, P. V., Troost, D., Meeteren, N. S.-V., Caron, H. N., Cloos, J. J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003088 · Cited by 715 · see citing works

Risk stratification of childhood medulloblastoma in the molecular era: the current consensus

Ramaswamy, V., Remke, M., Bouffet, E., Bailey, S., Clifford, S. C., Doz, F., Kool, M., Dufour, C., Vassal, G., Milde, T., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1569-6 · Cited by 654 · see citing works

cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas

Brat, D. J., Aldape, K., Colman, H., Figarella‐Branger, D., Fuller, G. N., Giannini, C., Holland, E. C., Jenkins, R. B., Kleinschmidt-DeMasters, B. K., Komori, T., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02127-9 · Cited by 523 · see citing works

cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading

Louis, D. N., Wesseling, P., Aldape, K., Brat, D. J., Capper, D., Cree, I. A., Eberhart, C. G., Figarella-Branger, D. F., Fouladi, M., Fuller, G. N., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12832 · Cited by 523 · see citing works

Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial

Fangusaro, J., Onar‐Thomas, A., Poussaint, T. Y., Wu, S., Ligon, A. H., Lindeman, N. I., Banerjee, A., Packer, R. J., Kilburn, L. B., Goldman, S., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30277-3 · Cited by 512 · see citing works

Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma

Zhukova, N., Ramaswamy, V., Remke, M., Pfaff, E., Shih, D. J. H., Martin, D. C., Castelo‐Branco, P., Baskin, B., Ray, P. N., Bouffet, É., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5052 · Cited by 482 · see citing works

Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas

Ryall, S. T., Zápotocký, M., Fukuoka, K., Nobre, L. F., Stücklin, A. G., Bennett, J., Siddaway, R., Li, C., Pajovic, S., Arnoldo, A., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.011 · Cited by 476 · see citing works

A clinically applicable integrative molecular classification of meningiomas

Nassiri, F., Liu, J., Patil, V. S., Mamatjan, Y., Wang, J. Z., Hugh-White, R., Macklin, A. M., Khan, S., Singh, O., Karimi, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03850-3 · Cited by 459 · see citing works

Novel, improved grading system(s) for IDH-mutant astrocytic gliomas

Shirahata, M., Ono, T., Stichel, D., Schrimpf, D., Reuß, D., Sahm, F., Koelsche, C., Wefers, A. K., Reinhardt, A., Huang, K. T. L., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1849-4 · Cited by 452 · see citing works

Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group

Ater, J. L., Zhou, T., Holmes, E. J., Mazewski, C., Booth, T. N., Freyer, D. R., Lazarus, K. H., Packer, R. J., Prados, M. D., Sposto, R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.6054 · Cited by 435 · see citing works

TERT Promoter Mutations and Risk of Recurrence in Meningioma

Sahm, F., Schrimpf, D., Olar, A., Koelsche, C., Reuß, D., Bissel, J., Kratz, A., Capper, D., Schefzyk, S., Hielscher, T., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv377 · Cited by 407 · see citing works

Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology

Qaddoumi, I. A., Orisme, W., Wen, J., Santiago, T., Gupta, K., Dalton, J., Tang, B., Haupfear, K., Punchihewa, C., Easton, J. B., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1539-z · Cited by 403 · see citing works

Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group

Cohen, K. J., Pollack, I. F., Zhou, T., Buxton, A. B., Holmes, E. J., Burger, P. C., Brat, D. J., Rosenblum, M. K., Hamilton, R. L., Lavey, R. S., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/noq191 · Cited by 396 · see citing works

cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant

Louis, D. N., Giannini, C., Capper, D., Paulus, W., Figarella-Branger, D. F., Lopes, M. B. S., Batchelor, T. T., Cairncross, J. G., van den Bent, M. J., Wick, W., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1826-y · Cited by 395 · see citing works

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

van den Bent, M. J., Baumert, B. G., Erridge, S., Vogelbaum, M. A., Nowak, A. K., Sanson, M., Brandes, A. A., Clément, P. M., Baurain, J. F., Mason, W. P., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31442-3 · Cited by 389 · see citing works

Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial

Wen, P. Y., Stein, A., van den Bent, M. J., Greve, J. D., Wick, A., Vos, F. D., von Bubnoff, N., van Linde, M. E., Lai, A., Prager, G. W., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00578-7 · Cited by 377 · see citing works

BRAF Inhibition in BRAF V600 -Mutant Gliomas: Results From the VE-BASKET Study

Kaley, T. J., Touat, M., Subbiah, V., Hollebecque, A., Rodon, J. A., Lockhart, A. C., Keedy, V. L., Bielle, F., Hofheinz, R., Joly, F., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.9990 · Cited by 353 · see citing works

The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants

Pajtler, K. W., Mack, S. C., Ramaswamy, V., Smith, C. A., Witt, H., Smith, A., Hansford, J. R., von Hoff, K., Wright, K. D., Hwang, E. I., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1643-0 · Cited by 337 · see citing works

Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study

van den Bent, M. J., Tesileanu, C. M. S., Wick, W., Sanson, M., Brandes, A. A., Clément, P. M., Erridge, S., Vogelbaum, M. A., Nowak, A. K., Baurain, J. F., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00090-5 · Cited by 332 · see citing works

Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes

Sharma, T., Schwalbe, E. C., Williamson, D., Sill, M., Hovestadt, V., Mynarek, M., Rutkowski, S., Robinson, G. W., Gajjar, A., Cavalli, F., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02020-0 · Cited by 310 · see citing works

Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers

Yip, S. S. F., Butterfield, Y. S. N., Morozova, O., Chittaranjan, S., Blough, M. D., An, J., Birol, İ., Chesnelong, C., Chiu, R., Chuah, E., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2995 · Cited by 307 · see citing works

Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities

Choudhury, A., Magill, S. T., Eaton, C. D., Prager, B. C., Chen, W. C., Cady, M. A., Seo, K., Lucas, C. G., Casey-Clyde, T., Vasudevan, H. N., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01061-8 · Cited by 303 · see citing works

Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations

Reinhardt, A., Stichel, D., Schrimpf, D., Sahm, F., Korshunov, A., Reuß, D., Koelsche, C., Huang, K. T. L., Wefers, A. K., Hovestadt, V., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1837-8 · Cited by 300 · see citing works

EANO guidelines for the diagnosis and treatment of ependymal tumors

Rudà, R., Reifenberger, G., Frappaz, D., Pfister, S. M., Laprie, A., Santarius, T., Roth, P., Tonn, J. C., Soffietti, R., Weller, M., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox166 · Cited by 297 · see citing works

Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas

Fontebasso, A. M., Schwartzentruber, J., Khuong-Quang, D.-A., Liu, X.-Y., Sturm, D., Korshunov, A., Jones, D., Witt, H., Kool, M., Albrecht, S., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1095-8 · Cited by 291 · see citing works

cIMPACT‐NOW update 7: advancing the molecular classification of ependymal tumors

Ellison, D. W., Aldape, K., Capper, D., Fouladi, M., Gilbert, M. R., Gilbertson, R. J., Hawkins, C. E., Merchant, T. E., Pajtler, K. W., Venneti, S., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12866 · Cited by 278 · see citing works

CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas

Appay, R., Dehais, C., Maurage, C., Alentorn, A., Carpentier, C., Colin, C., Ducray, F., Escande, F., Idbaïh, A., Kamoun, A., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz124 · Cited by 275 · see citing works

All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2

Labussière, M., Idbaïh, A., Wang, X.-W., Marie, Y., Boisselier, B., Falet, C., Paris, S., Laffaire, J., Carpentier, C., Crinière, E., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e1cf3a · Cited by 274 · see citing works

Medulloblastomics revisited: biological and clinical insights from thousands of patients

Hovestadt, V., Ayrault, O., Swartling, F. J., Robinson, G. W., Pfister, S. M., & Northcott, P. A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0223-8 · Cited by 271 · see citing works

Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma

Sahm, F., Reuß, D., Koelsche, C., Capper, D., Schittenhelm, J., Heim, S., Jones, D., Pfister, S. M., Herold‐Mende, C. C., Wick, W., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1326-7 · Cited by 271 · see citing works

Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes

Clarke, M., Mackay, A. G., Ismer, B., Pickles, J. C., Tatevossian, R., Newman, S., Bale, T., Stoler, I., Izquierdo, E., Temelso, S., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1030 · Cited by 270 · see citing works

DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management

Nassiri, F., Mamatjan, Y., Suppiah, S., Badhiwala, J. H., Mansouri, S., Karimi, S., Saarela, O., Poisson, L., Gepfner‐Tuma, I., Schittenhelm, J., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz061 · Cited by 267 · see citing works

Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated

Maas, S. L. N., Stichel, D., Hielscher, T., Sievers, P., Berghoff, A. S., Schrimpf, D., Sill, M., Euskirchen, P., Blume, C., Patel, A., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00784 · Cited by 260 · see citing works

Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome

Panwalkar, P., Clark, J. R., Ramaswamy, V., Hawes, D., Yang, F., Dunham, C. P., Yip, S. S. F., Hukin, J., Sun, Y., Schipper, M. J., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1752-4 · Cited by 250 · see citing works

cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation

Ellison, D. W., Hawkins, C. E., Jones, D., Onar‐Thomas, A., Pfister, S. M., Reifenberger, G., & Louis, D. N. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01987-0 · Cited by 246 · see citing works

The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications

Wen, P. Y., & Packer, R. J. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab120 · Cited by 241 · see citing works

Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma

Merchant, T. E., Bendel, A. E., Sabin, N. D., Burger, P. C., Shaw, D., Chang, E. L., Wu, S., Zhou, T., Eisenstat, D. D., Foreman, N. K., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01765 · Cited by 241 · see citing works

Outcomes by clinical and molecular features in children with medulloblastoma treated with risk-adapted therapy: results of an international phase III trial (SJMB03)

Gajjar, A., Robinson, G. W., Smith, K. S., Lin, T., Merchant, T. E., Chintagumpala, M., Mahajan, A., Su, J., Bouffet, E., Bartels, U., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01372 · Cited by 241 · see citing works

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial

Robinson, G. W., Rudneva, V. A., Buchhalter, I., Billups, C. A., Waszak, S. M., Smith, K. S., Bowers, D. C., Bendel, A. E., Fisher, P. G., Partap, S., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30204-3 · Cited by 238 · see citing works

Phase II Study of Weekly Vinblastine in Recurrent or Refractory Pediatric Low-Grade Glioma

Bouffet, É., Jakacki, R. I., Goldman, S., Hargrave, D. R., Hawkins, C. E., Shroff, M. M., Hukin, J., Bartels, U. K., Foreman, N. K., Kellie, S. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.5843 · Cited by 231 · see citing works

A molecularly integrated grade for meningioma

Driver, J., Hoffman, S. E., Tavakol, S., Woodward, E. L., Maury, E. A., Bhave, V. M., Greenwald, N. F., Nassiri, F., Aldape, K., Zadeh, G. M., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab213 · Cited by 229 · see citing works

cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC)

Louis, D. N., Wesseling, P., Paulus, W., Giannini, C., Batchelor, T. T., Cairncross, J. G., Capper, D., Figarella-Branger, D. F., Lopes, M. B. S., Wick, W., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1808-0 · Cited by 226 · see citing works

Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1

Ramkissoon, L. A., Horowitz, P. M., Craig, J. M., Ramkissoon, S. H., Rich, B. E., Schumacher, S. E., McKenna, A., Lawrence, M. S., Bergthold, G., Brastianos, P. K., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300252110 · Cited by 225 · see citing works

Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas

Karajannis, M. A., Legault, G., Fisher, M. J., Milla, S. S., Cohen, K. J., Wisoff, J. H., Harter, D. H., Goldberg, J. D., Hochman, T., Merkelson, A., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou059 · Cited by 224 · see citing works

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma

Bell, E. H., Zhang, P., Shaw, E. G., Buckner, J. C., Barger, G. R., Bullard, D. E., Mehta, M. P., Gilbert, M. R., Brown, P. D., Stelzer, K. J., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02983 · Cited by 219 · see citing works

Children’s oncology group phase III trial of reduced-dose and reduced-volume radiotherapy with chemotherapy for newly diagnosed average-risk medulloblastoma

Michalski, J. M., Janss, A. J., Vezina, L. G., Smith, K. S., Billups, C. A., Burger, P. C., Embry, L. M., Cullen, P. L., Hardy, K. K., Pomeroy, S. L., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.02730 · Cited by 215 · see citing works

Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis

Ramaswamy, V., Hielscher, T., Mack, S. C., Lassaletta, Á., Lin, T., Pajtler, K. W., Jones, D., Luu, B., Cavalli, F. M. G., Aldape, K., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.7825 · Cited by 205 · see citing works

High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539

Rogers, L., Won, M., Vogelbaum, M. A., Perry, A., Ashby, L. S., Modi, J. M., Alleman, A. M., Galvin, J. M., Fogh, S. E., Youssef, E. F., et al. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.11.028 · Cited by 201 · see citing works

Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis

Chen, C. C. L., Deshmukh, S., Jessa, S., Hadjadj, D., Lisi, V., Andrade, A. F., Faury, D., Jawhar, W., Dali, R., Suzuki, H., et al. (2020) · Cell · doi:10.1016/j.cell.2020.11.012 · Cited by 190 · see citing works

MYCN amplification drives an aggressive form of spinal ependymoma

Ghasemi, D. R., Sill, M., Okonechnikov, K., Korshunov, A., Yip, S. S. F., Schütz, P. W., Scheie, D., Kruse, A., Harter, P. N., Kastelan, M., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02056-2 · Cited by 189 · see citing works

IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children’s Oncology Group

for the Children’s Oncology Group, Pollack, I. F., Hamilton, R. L., Sobol, R. W., Nikiforova, M. N., Lyons‐Weiler, M. A., LaFramboise, W. A., Burger, P. C., Brat, D. J., Rosenblum, M. K., et al. (2010) · Child s Nervous System · doi:10.1007/s00381-010-1264-1 · Cited by 185 · see citing works

Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study

Jakacki, R. I., Cohen, K. J., Buxton, A. B., Krailo, M., Burger, P. C., Rosenblum, M. K., Brat, D. J., Hamilton, R. L., Eckel, S. P., Zhou, T., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now038 · Cited by 183 · see citing works

Pediatric low-grade gliomas: next biologically driven steps

Jones, D., Kieran, M. W., Bouffet, É., Alexandrescu, S., Bandopadhayay, P., Bornhorst, M., Ellison, D. W., Fangusaro, J., Fisher, M. J., Foreman, N. K., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox141 · Cited by 169 · see citing works

Advances in multidisciplinary therapy for meningiomas

Brastianos, P. K., Galanis, E., Butowski, N. A., Chan, J. W. S., Dunn, I. F., Goldbrunner, R., Herold‐Mende, C. C., Ippen, F. M., Mawrin, C., McDermott, M. W., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy136 · Cited by 165 · see citing works

Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children’s Oncology Group

Leary, S. E. S., Packer, R. J., Li, Y., Billups, C. A., Smith, K. S., Jaju, A., Heier, L., Burger, P., Walsh, K., Han, Y., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.2224 · Cited by 164 · see citing works

What do we know about IDH1/2 mutations so far, and how do we use it?

Horbinski, C. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1106-9 · Cited by 163 · see citing works

Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy

Louis, D. N., Aldape, K. D., Brat, D. J., Capper, D., Ellison, D. W., Hawkins, C. E., Paulus, W., Perry, A., Reifenberger, G., Figarella-Branger, D. F., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1646-x · Cited by 155 · see citing works

Pediatric low-grade gliomas: implications of the biologic era

Packer, R. J., Pfister, S. M., Bouffet, É., Avery, R. A., Bandopadhayay, P., Bornhorst, M., Bowers, D. C., Ellison, D. W., Fangusaro, J., Foreman, N. K., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now209 · Cited by 154 · see citing works

Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients

MacDonald, S. M., Sethi, R., Lavally, B. L., Yeap, B. Y., Marcus, K. J., Caruso, P. A., Pulsifer, M., Huang, M., Ebb, D. H., Tarbell, N. J., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not121 · Cited by 150 · see citing works

Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated

Maas, S. L. N., Stichel, D., Hielscher, T., Sievers, P., Berghoff, A. S., al, E., Rushing, E. J., Wirsching, H., & Weller, M. (2021) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-209406 · Cited by 129 · see citing works

Ependymoma: Evaluation and Management Updates

Rudà, R., Bruno, F., Pellerino, A., & Soffietti, R. (2022) · Current Oncology Reports · doi:10.1007/s11912-022-01260-w · Cited by 129 · see citing works

Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High‐Dose Chemotherapy

Lafay‐Cousin, L., Smith, A., Chi, S. N., Wells, E. M., Madden, J. R., Margol, A., Ramaswamy, V., Finlay, J. L., Taylor, M. D., Dhall, G., et al. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26042 · Cited by 129 · see citing works

PL1.1 CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDHmutant gliomas

Appay, R., Dehais, C., Colin, C., Alentorn, A., Carpentier, C., Ducray, F., Ibdaih, A., Kamoun, A., Mokhtari, K., Tabouret, E., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz126.000 · Cited by 126 · see citing works

High‐grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication—a comprehensive clinical, radiographic, pathologic, and genomic analysis

Ferris, S. P., Vega, J. E. V., Aboian, M., Lee, J. C., Ziffle, J. V., Onodera, C. S., Grenert, J. P., Saunders, T., Chen, Y.-Y., Banerjee, A., et al. (2019) · Brain Pathology · doi:10.1111/bpa.12747 · Cited by 119 · see citing works

Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma

Ziegler, D. S., Wong, M., Mayoh, C., Kumar, A., Tsoli, M., Mould, E. V. A., Tyrrell, V. J., Khuong-Quang, D.-A., Pinese, M., Gayevskiy, V., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0251-2 · Cited by 116 · see citing works

Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial

Goschzik, T., Schwalbe, E. C., Hicks, D., Smith, A. J., Muehlen, A. Z., Figarella-Branger, D. F., Doz, F., Rutkowski, S., Lannering, B., Pietsch, T., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30532-1 · Cited by 113 · see citing works

Gone FISHing: Clinical Lessons Learned in Brain Tumor Molecular Diagnostics over the Last Decade

Horbinski, C., Miller, C. R., & Perry, A. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00453.x · Cited by 109 · see citing works

Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort

Mynarek, M., von Hoff, K., Pietsch, T., Ottensmeier, H., Warmuth‐Metz, M., Bison, B., Pfister, S. M., Korshunov, A., Sharma, T., Jäger, N., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.03057 · Cited by 107 · see citing works

Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q

Baroni, L., Sundaresan, L., Heled, A., Coltin, H., Pajtler, K. W., Lin, T., Merchant, T. E., McLendon, R. E., Faria, C. C., Buntine, M. K., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab034 · Cited by 90 · see citing works

ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma

Arabzade, A., Zhao, Y., Varadharajan, S., Chen, H., Jessa, S., Rivas, B. L., Stuckert, A. J., Solis, M., Kardian, A., Tlais, D., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1066 · Cited by 89 · see citing works

Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report

Armstrong, T. S., Dirven, L., Arons, D. F., Bates, A., Chang, S. M., Coens, C., Espinasse, C., Gilbert, M. R., Jenkinson, D., Kluetz, P. G., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30796-x · Cited by 86 · see citing works

Molecular characterization of histopathological ependymoma variants

Neumann, J. E., Spohn, M., Obrecht, D., Mynarek, M., Thomas, C., Hasselblatt, M., Dorostkar, M. M., Wefers, A. K., Frank, S., Monoranu, C., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02090-0 · Cited by 86 · see citing works

Isocitrate Dehydrogenase 1 Analysis Differentiates Gangliogliomas from Infiltrative Gliomas

Horbinski, C., Kofler, J., Yeaney, G. A., Camelo-Piragua, S. I., Venneti, S., Louis, D. N., Perry, A., MURDOCH, G. H., & Nikiforova, M. N. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00480.x · Cited by 79 · see citing works

Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1‐deficient non‐rhabdoid tumor with favorable long‐term outcome

Johann, P. D., Hovestadt, V., Thomas, C., Jeibmann, A., Heß, K., Bens, S., Oyen, F., Hawkins, C. E., Pierson, C. R., Aldape, K., et al. (2016) · Brain Pathology · doi:10.1111/bpa.12413 · Cited by 79 · see citing works

Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children’s Oncology Group (ACNS1221)

Lafay‐Cousin, L., Bouffet, É., Strother, D. R., Rudneva, V. A., Hawkins, C. E., Eberhart, C. G., Horbinski, C., Heier, L., Souweidane, M. M., Williams‐Hughes, C., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.00845 · Cited by 78 · see citing works

Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH -wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial

Tesileanu, C. M. S., Sanson, M., Wick, W., Brandes, A. A., Clément, P. M., Erridge, S., Vogelbaum, M. A., Nowak, A. K., Baurain, J., Mason, W. P., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-4283 · Cited by 76 · see citing works

Subgroup and subtype-specific outcomes in adult medulloblastoma

Coltin, H., Sundaresan, L., Smith, K. S., Skowron, P., Massimi, L., Eberhart, C. G., Schreck, K. C., Gupta, N. M., Weiss, W. A., Tirapelli, D. P. D. C., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02358-4 · Cited by 75 · see citing works

The biology of ependymomas and emerging novel therapies

Saleh, A. H., Samuel, N., Juraschka, K., Saleh, M. H., Taylor, M. D., & Fehlings, M. G. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-021-00433-2 · Cited by 73 · see citing works

The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients

Horbinski, C., Ligon, K. L., Brastianos, P. K., Huse, J. T., Venere, M., Chang, S. M., Buckner, J. C., Cloughesy, T. F., Jenkins, R. B., Giannini, C., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz119 · Cited by 70 · see citing works

Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial

Clifford, S. C., the SIOP-Europe PNET Group, Lannering, B., Schwalbe, E. C., Hicks, D., Toole, K., Nicholson, S. L., Goschzik, T., Mühlen, A. Z., Figarella-Branger, D. F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5149 · Cited by 64 · see citing works

Myxopapillary ependymomas in children: imaging, treatment and outcomes

Bandopadhayay, P., Silvera, V. M., Ciarlini, P. D. S. C., Malkin, H., Bi, W. L., Bergthold, G., Faisal, A. M., Ullrich, N. J., Marcus, K. J., Scott, R. M., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1955-2 · Cited by 60 · see citing works

Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort

Rhun, É. L., Devos, P., Winklhofer, S. F.-X., Lmalem, H., Brandsma, D., Kumthekar, P., Castellano, A., Compter, A., Dhermain, F. G., Franceschi, E., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac043 · Cited by 47 · see citing works

TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymoma

Thomas, C., Thierfelder, F., Träger, M., Soschinski, P., Müther, M., Edelmann, D., Förster, A., Geiler, C., Kim, H., Filipski, K., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02300-8 · Cited by 44 · see citing works

Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups

Hinrichs, B. H., Newman, S., Appin, C., Dunn, W. D., Cooper, L., Pauly, R., Kowalski, J., Rossi, M. R., & Brat, D. J. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0270-7 · Cited by 34 · see citing works

Long-Term Surgical Resection Outcomes of Pediatric Myxopapillary Ependymoma: Experience of Two Centers and Brief Literature Review

Abdallah, A., Emel, E., Gündüz, H. B., Sofuoğlu, Ö. E., Asiltürk, M., & Abdallah, B. G. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.12.128 · Cited by 29 · see citing works

High-Dose Chemotherapy in Children with Newly Diagnosed Medulloblastoma

Lafay‐Cousin, L., & Dufour, C. (2022) · Cancers · doi:10.3390/cancers14030837 · Cited by 27 · see citing works

Cumulative survival analysis of patients with spinal myxopapillary ependymomas in the first 2 decades of life

Kukreja, S., Ambekar, S., Sin, A. H., & Nanda, A. (2014) · Journal of Neurosurgery Pediatrics · doi:10.3171/2014.1.peds13532 · Cited by 23 · see citing works

Treatment and outcome of intracranial ependymoma after first relapse in the 2nd AIEOP protocol

Massimino, M., Barretta, F., Modena, P., Johann, P. D., Ferroli, P., Antonelli, M., Gandola, L., Garrè, M. L., Bertin, D., Mastronuzzi, A., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab230 · Cited by 17 · see citing works

Improved seizure control in patients with recurrent glioblastoma treated with bevacizumab

Hertler, C., Seystahl, K., Rhun, É. L., Wirsching, H., Roth, P., Weller, M., & Gramatzki, D. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac172 · Cited by 16 · see citing works

Mini‐symposium in medulloblastoma genomics in the modern molecular era

Ellison, D. W. (2020) · Brain Pathology · doi:10.1111/bpa.12838 · Cited by 15 · see citing works

Evaluation and Diagnosis of Central Nervous System Embryonal Tumors (Non-Medulloblastoma)

Cotter, J. A., & Judkins, A. R. (2022) · Pediatric and Developmental Pathology · doi:10.1177/10935266211018554 · Cited by 15 · see citing works

A Unique Case Report of Infant-Type Hemispheric Glioma (Gliosarcoma Subtype) with TPR-NTRK1 Fusion Treated with Larotrectinib

Mançano, B. M., dos Reis, M. B., Moreno, D. A., de Paula, F. E., Junior, C. R. D. A., Cavalcante, C. E. B., Zanon, M. F., Santana, I. V. V., Matsushita, M. D. M., & Reis, R. M. (2022) · Pathobiology · doi:10.1159/000521253 · Cited by 15 · see citing works

Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial

Draaisma, K., Tesileanu, C. M. S., de Heer, I., Klein, M., Smits, M., Reijneveld, J. C., Clément, P. M., Vos, F. D., Wick, A., Mulholland, P. J., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-3725 · Cited by 3 · see citing works

RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults

Wen, P. Y., van den Bent, M. J., Youssef, G., Cloughesy, T. F., Ellingson, B. M., Weller, M., Galanis, E., Barboriak, D. P., de Groot, J., Gilbert, M. R., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.01059 · Cited by 519 · see citing works

Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization

Wang, W., Li, T., Cheng, Y., Li, F., Qi, S., Mao, M., Wu, J., Liu, Q., Zhang, X., Li, X., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.03.013 · Cited by 231 · see citing works

Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme

Sosinsky, A., Ambrose, J. C., Cross, W. C. H., Turnbull, C., Henderson, S. J., Jones, J. L., Hamblin, A. D., Arumugam, P., Chan, G. C., Chubb, D., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02682-0 · Cited by 179 · see citing works

Oxamate enhances the efficacy of CAR-T therapy against glioblastoma via suppressing ectonucleotidases and CCR8 lactylation

Sun, T., Liu, B., Li, Y., Wu, J., Cao, Y., Yang, S., Tan, H., Cai, L., Zhang, S., Qi, X., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02815-w · Cited by 154 · see citing works

Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline

Sahm, F., Brandner, S., Bertero, L., Capper, D., French, P. J., Figarella-Branger, D. F., Giangaspero, F., Haberler, C., Hegi, M. E., Kristensen, B. W., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad100 · Cited by 113 · see citing works

Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors

Guo, X., Gu, L., Li, Y., Zheng, Z., Chen, W., Wang, Y., Wang, Y., Xing, H., Shi, Y., Liu, D., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1200815 · Cited by 93 · see citing works

Blood–Brain Barrier Conquest in Glioblastoma Nanomedicine: Strategies, Clinical Advances, and Emerging Challenges

Duan, M., Cao, R., Yang, Y., Chen, X., Liu, L., Ren, B., Wang, L., & Goh, B.-C. (2024) · Cancers · doi:10.3390/cancers16193300 · Cited by 84 · see citing works

Advanced MR Techniques for Preoperative Glioma Characterization: Part 1

Hirschler, L., Sollmann, N., Schmitz‐Abecassis, B., Pinto, J., Arzanforoosh, F., Barkhof, F., Booth, T. C., Calvo‐Imirizaldu, M., Cassia, G. D. S. E., Chmelík, M., et al. (2023) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28662 · Cited by 83 · see citing works

Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives

Chiu, F.-Y., & Yen, Y. (2023) · Biomarker Research · doi:10.1186/s40364-023-00476-7 · Cited by 83 · see citing works

Adult type diffuse gliomas in the new 2021 WHO Classification

Antonelli, M., & Poliani, P. L. (2022) · Pathologica · doi:10.32074/1591-951x-823 · Cited by 70 · see citing works

The complex interactions between the cellular and non-cellular components of the brain tumor microenvironmental landscape and their therapeutic implications

Faisal, S. M., Comba, A., Varela, M. L., Argento, A. E., Brumley, E. K., Abel, C. C., Castro, M. G., & Lowenstein, P. R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1005069 · Cited by 57 · see citing works

Soft and stretchable organic bioelectronics for continuous intraoperative neurophysiological monitoring during microsurgery

Zhou, W., Jiang, Y., Xu, Q., Chen, L., Qiao, H., Wang, Y., Lai, J., Zhong, D., Zhang, Y., Li, W., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01069-3 · Cited by 55 · see citing works

Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastoma

Zhong, Y., Geng, F., Mazik, L., Yin, X., Becker, A. P., Mohammed, S., Su, H., Xing, E., Kou, Y., Chiang, C.-Y., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101706 · Cited by 47 · see citing works

Applications of artificial intelligence in the analysis of histopathology images of gliomas: a review

Redlich, J.-P., Feuerhake, F., Weis, J., Schaadt, N. S., Teuber‐Hanselmann, S., Buck, C., Luttmann, S., Eberle, A., Nikolin, S., Appenzeller, A., et al. (2024) · npj Imaging · doi:10.1038/s44303-024-00020-8 · Cited by 47 · see citing works

Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors

Guo, X., Shi, Y., Liu, D., Li, Y., Chen, W., Wang, Y., Wang, Y., Xing, H., Xia, Y., Li, J., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1131642 · Cited by 41 · see citing works

G9a promotes immune suppression by targeting the Fbxw7/Notch pathway in glioma stem cells

Cao, Y., Liu, B., Cai, L., Li, Y., Huang, Y., Zhou, Y., Sun, X., Yang, W., & Sun, T. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14191 · Cited by 38 · see citing works

Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?

d’Amati, A., Bargiacchi, L., Rossi, S., Carai, A., Bertero, L., Barresi, V., Errico, M. E., Buccoliero, A. M., Asioli, S., Marucci, G., et al. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1268038 · Cited by 39 · see citing works

High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma

Pöhlmann, J., Weller, M., Marcellusi, A., Grabe-Heyne, K., Krott-Coi, L. M., Rabar, S., & Pollock, R. F. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1368606 · Cited by 35 · see citing works

Molecular pathology and clinical implications of diffuse glioma

Chai, R., Fang, S., Pang, B., Liu, Y., Wang, Y., Zhang, W., & Jiang, T. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002446 · Cited by 34 · see citing works

Genomic profiling and prognostic factors of H3 K27M ‐mutant spinal cord diffuse glioma

Chai, R., Yan, H., An, S., Pang, B., Chen, H., Mu, Q., Zhang, K., Zhang, Y.-W., Liu, Y., Liu, X., et al. (2023) · Brain Pathology · doi:10.1111/bpa.13153 · Cited by 34 · see citing works

5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy

Howley, R., Chandratre, S., & Chen, B. (2023) · Bioengineering · doi:10.3390/bioengineering10040496 · Cited by 33 · see citing works

Isocitrate dehydrogenase mutations in gliomas: A review of current understanding and trials

Sharma, N., Mallela, A. N., Shi, D. D., Tang, L. W., Abou‐Al‐Shaar, H., Gersey, Z. C., Zhang, X., McBrayer, S. K., & Abdullah, K. G. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad053 · Cited by 33 · see citing works

Role of N6-methyladenosine methylation in glioma: recent insights and future directions

Li, C., Li, B., Wang, H., Qu, L., Liu, H., Weng, C., Han, J., & Li, Y. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00514-0 · Cited by 35 · see citing works

Spatially resolved transcriptomics and graph-based deep learning improve accuracy of routine CNS tumor diagnostics

Ritter, M., Blume, C., Tang, Y., Patel, A., Patel, B., Berghaus, N., Benotmane, J. K., Kueckelhaus, J., Yabo, Y. A., Zhang, J., et al. (2025) · Nature Cancer · doi:10.1038/s43018-024-00904-z · Cited by 32 · see citing works

Exosomes in Glioma: Unraveling Their Roles in Progression, Diagnosis, and Therapy

Yang, S., Sun, Y., Liu, W., Zhang, Y. Q., Sun, G., Xiang, B., & Yang, J. (2024) · Cancers · doi:10.3390/cancers16040823 · Cited by 34 · see citing works

Brain gliomas: Diagnostic and therapeutic issues and the prospects of drug-targeted nano-delivery technology

Song, B., Wang, X., Qin, L., Hussain, S., & Liang, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107308 · Cited by 30 · see citing works

Distinct tumor-TAM interactions in IDH-stratified glioma microenvironments unveiled by single-cell and spatial transcriptomics

Motevasseli, M., Darvishi, M., Khoshnevisan, A., Zeinalizadeh, M., Saffar, H., Bayat, S., Najafi, A., Abbaspour, M. J., Mamivand, A., Olson, S. B., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01837-5 · Cited by 30 · see citing works

Targeting DNM1L/DRP1-FIS1 axis inhibits high-grade glioma progression by impeding mitochondrial respiratory cristae remodeling

Li, X., Tie, J.-J., Sun, Y., Gong, C., Deng, S., Chen, X., Li, S., Wang, Y., Wang, Z., Wu, F., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03194-6 · Cited by 29 · see citing works

Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesis

Goenka, A., Song, X., Tiek, D. M., Iglesia, R. P., Lu, M., Zeng, C., Horbinski, C., Zhang, W., Hu, B., & Cheng, S. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad065 · Cited by 28 · see citing works

Lower-grade gliomas surgery guided by GRPR-targeting PET/NIR dual-modality image probe: a prospective and single-arm clinical trial

Chen, L., Zhang, J., Chi, C., Che, W., Dong, G., Wang, J., Du, Y., Wang, R., Zhu, Z., Tian, J., et al. (2024) · Theranostics · doi:10.7150/thno.91554 · Cited by 28 · see citing works

Long non-coding RNA in glioma: novel genetic players in temozolomide resistance

Roh, J., Im, M., Kang, J., Youn, B., & Kim, W. (2023) · Animal Cells and Systems · doi:10.1080/19768354.2023.2175497 · Cited by 28 · see citing works

AMPK-mediated CD47 H3K4 methylation promotes phagocytosis evasion of glioma stem cells post-radiotherapy

Sun, T., Liu, B., Cao, Y., Li, Y., Cai, L., & Yang, W. (2024) · Cancer Letters · doi:10.1016/j.canlet.2023.216605 · Cited by 27 · see citing works

Advances of artificial intelligence in clinical application and scientific research of neuro-oncology: Current knowledge and future perspectives

Zhan, Y., Hao, Y., Wang, X., & Guo, D. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104682 · Cited by 28 · see citing works

Dendrimer Technology in Glioma: Functional Design and Potential Applications

Gaitsch, H., Hersh, A. M., Alomari, S., & Tyler, B. (2023) · Cancers · doi:10.3390/cancers15041075 · Cited by 26 · see citing works

The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas

Song, J., Xu, Z., Fan, Q., Sun, Y., & Lin, X. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1198713 · Cited by 26 · see citing works

Mapping the developmental trajectory of human astrocytes reveals divergence in glioblastoma

Sojka, C., Wang, H. V., Bhatia, T. N., Li, Y., Chopra, P., Sing, A., Voss, A. J., King, A. T., Wang, F., Joseph, K., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-024-01583-9 · Cited by 24 · see citing works

Deep Learning Advances in Brain Tumor Classification: Leveraging VGG16 and MobileNetV2 for Accurate MRI Diagnostics

Alex David, S., Begum, A., Kalilulah, S. I., Ruth Naveena, N., Rajathi, K., & Hemalatha, D. (2024) · International Conference on Power, Energy, Control and Transmission Systems (ICPECTS) · doi:10.1109/icpects62210.2024.10780014 · Cited by 25 · see citing works

Targeted suppression of glioma by ultralow-dose x-ray–induced photodynamic therapy and gold-based nanoclusters in preclinical models

Li, S., Chen, S., Li, Y., Sun, W., Li, J., Deng, H., Ding, H., Wang, Z., Zhu, L., Liu, J., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adq5331 · Cited by 26 · see citing works

Microplastics and nanoplastics in brain tumours and the healthy human brain

Li, R. Q., Lin, F., Zhao, X., Wang, J., Teng, M., Li, C., Ma, L., Zhong, H., Chen, Y., Tang, W., et al. (2026) · Nature Health · doi:10.1038/s44360-026-00091-4 · Cited by 25 · see citing works

Molecular Profiling in Neuro-Oncology: Where We Are, Where We're Heading, and How We Ensure Everyone Can Come Along

Porter, A. B., Wen, P. Y., & Polley, M. C. (2023) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_389322 · Cited by 23 · see citing works

The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis

Groff, K. J., Patel, R. V., Feng, Y., Ghosh, H. S., Chavez, M. A. M., O’Brien, J., Chen, W. C., Nitturi, V., Save, A., Youngblood, M. W., et al. (2025) · The Lancet Oncology · doi:10.1016/s1470-2045(25)00422-x · Cited by 20 · see citing works

Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms

Fath, M. K., Babakhaniyan, K., Anjomrooz, M., Jalalifar, M.-R., Alizadeh, S. D., Pourghasem, Z., Oshagh, P. A., Azargoonjahromi, A., Almasi, F., Manzoor, H. Z., et al. (2022) · Vaccines · doi:10.3390/vaccines10091448 · Cited by 20 · see citing works

Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical Trials

Rahman, R., Janowski, M., Killick-Cole, C. L., Singleton, W., Campbell, E. L., Walczak, P., Khatua, S., Faltings, L., Symons, M. H., Schneider, J. R., et al. (2023) · Cancers · doi:10.3390/cancers15030857 · Cited by 21 · see citing works

Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment

Rahban, M., Joushi, S., Bashiri, H., Saso, L., & Sheibani, V. (2024) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1325214 · Cited by 20 · see citing works

The need for paradigm shift: prognostic significance and implications of standard therapy-related systemic immunosuppression in glioblastoma for immunotherapy and oncolytic virotherapy

Stepanenko, A. A., Sosnovtseva, A. O., Valikhov, M. P., Chernysheva, A. A., Abramova, O. V., Naumenko, V., & Chekhonin, V. P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1326757 · Cited by 19 · see citing works

Interactions between microglia and glioma in tumor microenvironment

Tao, J., Dong, Y. J., Shao, W., Zhou, D., Wang, Y., Hou, S., Deng, K., & Lin, N. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1236268 · Cited by 22 · see citing works

Stretching boundaries in neurophysiological monitoring

Hou, B., & Liu, X. (2023) · BMEMat · doi:10.1002/bmm2.12054 · Cited by 18 · see citing works

Grading diffuse glioma based on 2021 WHO grade using self-attention-base deep learning architecture: variable Vision Transformer (vViT)

Usuzaki, T., Takahashi, K., Inamori, R., Morishita, Y., Takagi, H., Shizukuishi, T., Toyama, Y., Abe, M., Ishikuro, M., Obara, T., et al. (2024) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2024.106001 · Cited by 18 · see citing works

Spatiotemporal Insights into Glioma Oncostream Dynamics: Unraveling Formation, Stability, and Disassembly Pathways

Faisal, S. M., Clewner, J. E., Stack, B., Varela, M. L., Comba, A., Abbud, G., Motsch, S., Castro, M. G., & Lowenstein, P. R. (2024) · Advanced Science · doi:10.1002/advs.202309796 · Cited by 18 · see citing works

Complement and coagulation cascades are associated with prognosis and the immune microenvironment of lower-grade glioma

Yang, J., Shen, L., Yang, J., Qu, Y., Gong, C., Zhou, F., Liu, Y., Luo, M., & Zhao, L. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-906 · Cited by 17 · see citing works

Multi-transcriptomics reveals niche-specific expression programs and endothelial cells in glioblastoma

Hu, J., Sa, X., Yang, Y., Han, Y., Wu, J., Sun, M., Shafi, S., Ahmad, N., Siraj, S., Yang, J., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06185-z · Cited by 16 · see citing works

Review of the Recent Changes in the WHO Classification for Pediatric Brain and Spinal Cord Tumors

Halfpenny, A. M., & Wood, M. D. (2023) · Pediatric Neurosurgery · doi:10.1159/000528957 · Cited by 16 · see citing works

Safety and Efficacy of Laser Interstitial Thermal Therapy as Upfront Therapy in Primary Glioblastoma and IDH-Mutant Astrocytoma: A Meta-Analysis

Pandey, A., Chandla, A., Mekonnen, M. A., Hovis, G. E. A., Teton, Z. E., Patel, K. S., Everson, R. G., Wadehra, M., & Yang, I. (2024) · Cancers · doi:10.3390/cancers16112131 · Cited by 16 · see citing works

Beyond conventional imaging: Advancements in MRI for glioma malignancy prediction and molecular profiling

Śledzińska, P., Furtak, J., Bebyn, M. G., & Serafin, Z. (2024) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2024.06.004 · Cited by 16 · see citing works

Glioma cell membrane camouflaged cinobufotalin delivery system for combinatorial orthotopic glioblastoma therapy

Song, Z., Zhao, L., Fang, W., Guo, S., Xu, A., Zhan, Z., Cai, Y., Xue, S., Chai, P., Jiang, Q., et al. (2023) · Nano Research · doi:10.1007/s12274-023-5807-7 · Cited by 15 · see citing works

Classification of the Type of Brain Tumor in MRI Using Xception Model

Cobilla, R., Dichoso, J. C., Miñon, A. B., Pascual, A. K., Abisado, M., Huyo-a, S. L., & Sampedro, G. A. (2023) · International Conference on Electronics, Information, and Communication (ICEIC) · doi:10.1109/iceic57457.2023.10049979 · Cited by 14 · see citing works

Bridging the age gap: a review of molecularly informed treatments for glioma in adolescents and young adults

Weiser, A., Bergman, A. S., Machaalani, C., Bennett, J., Roth, P., Reimann, R., Nazarian, J., & Stücklin, A. G. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1254645 · Cited by 14 · see citing works

Molecular biology and novel therapeutics for IDH mutant gliomas: The new era of IDH inhibitors

Kitagawa, Y., Kobayashi, A., Cahill, D. P., Wakimoto, H., & Tanaka, S. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189102 · Cited by 13 · see citing works

Targeting the Endocannabinoid System Present in the Glioblastoma Tumour Microenvironment as a Potential Anti-Cancer Strategy

Dasram, M. H., Naidoo, P., Walker, R. B., & Khamanga, S. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031371 · Cited by 13 · see citing works

Functional profiling of murine glioma models highlights targetable immune evasion phenotypes

Mikolajewicz, N., Tatari, N., Wei, J., Savage, N. J., Farias, A. G., Dimitrov, V., Chen, D. Y., Zador, Z. E., Dasgupta, K., Aguilera-Uribe, M., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02831-w · Cited by 12 · see citing works

Tumor-associated macrophage-derived exosomes modulate the immunotherapeutic sensitivity of SHH-medulloblastoma by targeting m6A-modified FOXD1

Liu, Y., Peng, Y., Song, C., Liu, Z., Yang, X., Bian, S., Xiao, X., Li, H., Wang, J., Sun, Z., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf123 · Cited by 12 · see citing works

Medical Treatment of Pediatric Low-Grade Glioma

Lim, Y. J. (2022) · Brain Tumor Research and Treatment · doi:10.14791/btrt.2022.0039 · Cited by 12 · see citing works

Combination of multi-modal MRI radiomics and liquid biopsy technique for preoperatively non-invasive diagnosis of glioma based on deep learning: protocol for a double-center, ambispective, diagnostical observational study

Hu, P., Xu, L., Qi, Y., Yan, T., Ye, L., Wen, S., Yuan, D., Zhu, X., Deng, S., Liu, X., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1183032 · Cited by 12 · see citing works

Predicting Histopathological Grading of Adult Gliomas Based On Preoperative Conventional Multimodal MRI Radiomics: A Machine Learning Model

Du, P., Liu, X., Wu, X., Chen, J., Cao, A., & Geng, D. (2023) · Brain Sciences · doi:10.3390/brainsci13060912 · Cited by 12 · see citing works

Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma

Richardson, T. E., Yokoda, R. T., Rashidipour, O., Vij, M., Snuderl, M., Brem, S. S., Hatanpaa, K. J., McBrayer, S. K., Abdullah, K. G., Umphlett, M., et al. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad085 · Cited by 12 · see citing works

Metformin-induced reduction of CCR8 enhances the anti-tumor immune response of PD-1 immunotherapy in glioblastoma

Li, Y., Liu, B., Cao, Y., Cai, L., Zhou, Y., Yang, W., & Sun, T. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176274 · Cited by 12 · see citing works

The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models

de la Nava, D., Ausejo‐Mauleon, I., Laspidea, V., González-Huarriz, M., Lacalle, A., Casares, N., Zalacaín, M., Marrodán, L., García-Moure, M., Ochoa, M. C., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae066 · Cited by 12 · see citing works

CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity

Liu, C., Yang, W., Chien, C.-H., Wu, C.-L., Chuang, J., Chen, P., Chu, J., Cheng, S. M., Qiu, L.-Y., Chang, Y.-C., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06784-6 · Cited by 12 · see citing works

A systematic review of data sources for artificial intelligence applications in pediatric brain tumors in Europe: implications for bias and generalizability

Tozzi, A. E., Croci, I., Voicu, I. P., Dotta, F., Colafati, G. S., Carai, A., Fabozzi, F., Lacanna, G., Premuselli, R., & Mastronuzzi, A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1285775 · Cited by 10 · see citing works

Intraoperative rapid molecular diagnosis aids glioma subtyping and guides precise surgical resection

Jia, L., Han, Z. W., Ma, C., Chi, H., Jia, D., Zhang, K., Feng, Z., Han, B., Qi, M., Li, G., et al. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52138 · Cited by 11 · see citing works

Spinal Cord Astroblastoma With EWSR1-BEND2 Fusion in Female Patients

Fu, L., Lao, I. W., Huang, L., Ou, L., Yuan, L., Li, Z., Li, S., Hu, W., & Xi, S. (2024) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000002298 · Cited by 11 · see citing works

Polymersome-enabled brain codelivery of STAT3 siRNA and CpG oligonucleotide boosts chemo-immunotherapy of malignant glioma

Zhao, S., Sun, Z., Xia, M., Guo, B., Qu, Y., Wang, J., Zhong, Z., & Meng, F. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113764 · Cited by 11 · see citing works

CD73 inhibitor AB680 suppresses glioblastoma in mice by inhibiting purine metabolism and promoting P2RY12+ microglia transformation

Gao, P., Jiang, H., Du, Y., Shu, Y., Wan, Y.-W., Yin, E., Wu, J., Liang, X.-X., Wang, S.-D., Ding, Z.-H., et al. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01585-9 · Cited by 12 · see citing works

Prediction of the Molecular Subtype of IDH Mutation Combined with MGMT Promoter Methylation in Gliomas via Radiomics Based on Preoperative MRI

Sha, Y., Yan, Q., Tan, Y. Q., Wang, X., Zhang, H., & Yang, G. (2023) · Cancers · doi:10.3390/cancers15051440 · Cited by 11 · see citing works

Clinical Assessment of Magnetic Resonance Spectroscopy and Diffusion-Weighted Imaging in Diffuse Glioma: Insights Into Histological Grading and IDH Classification

Zhang, H., Zhang, H., Liu, X., Deng, H.-Z., Zhang, Y., Tang, X.-M., Lin, F., & Huang, B. (2024) · Canadian Association of Radiologists Journal · doi:10.1177/08465371241238917 · Cited by 10 · see citing works

Cisplatin reduces immunosuppression caused by tumor-associated macrophages through downregulating CD47-SIRPα signaling in glioblastoma

Li, Y., Cao, Y., He, L., Wu, J., Cai, L., Zhou, Y., Li, H., Yang, W., & Sun, T. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167876 · Cited by 10 · see citing works

Perioperative corticosteroid treatment impairs tumor-infiltrating dendritic cells in patients with newly diagnosed adult-type diffuse gliomas

Carenza, C., Franzese, S., Castagna, A., Terzoli, S., Simonelli, M., Persico, P., Bello, L., Nibali, M. C., Pessina, F., Kunderfranco, P., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1074762 · Cited by 10 · see citing works

MAPK9 is Correlated with a Poor Prognosis and Tumor Progression in Glioma

Yang, X., Jia, Q., Liu, X., Wu, W., Han, Y., Zou, Z., Li, M., Fan, D., Song, J., & Chen, L. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2803063 · Cited by 10 · see citing works

Polyphyllin I induces apoptosis and autophagy in temozolomide-resistant glioma via modulation of NRF2 and MAPK-signaling activation

Feng, F., Sun, C., Wang, X., Zhang, H., & Cheng, P. (2023) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2023.2199553 · Cited by 10 · see citing works

CDKN2A/B co-deletion is associated with increased risk of local and distant intracranial recurrence after surgical resection of brain metastases

Morshed, R. A., Nguyen, M., Cummins, D. D., Saggi, S. S., Young, J. S., Haddad, A. F., Goldschmidt, E., Chang, E. F., McDermott, M. W., Berger, M. S., et al. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad007 · Cited by 10 · see citing works

Causal relationship between type 2 diabetes and glioblastoma: bidirectional Mendelian randomization analysis

Chen, W., Zhang, T., & Zhang, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-67341-x · Cited by 9 · see citing works

NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K /Akt activation

Zhang, A., Peng, S., Sun, S., Ye, S., Zhao, Y., & Wu, Q. (2024) · Cancer Medicine · doi:10.1002/cam4.70100 · Cited by 9 · see citing works

Advances in the Repurposing and Blood–Brain Barrier Penetrance of Drugs in Pediatric Brain Tumors

Rechberger, J. S., Toll, S. A., Biswas, S., You, H. B., Chow, W. D., Kendall, N. A. S., Navalkele, P. D., & Khatua, S. (2025) · Cancers · doi:10.3390/cancers17030439 · Cited by 11 · see citing works

Multiparametric radiomics signature for predicting molecular genotypes in adult-type diffuse gliomas utilizing 18F-FET PET/MRI

Bai, J., Cui, B., Li, F., Han, X., Yang, H., & Lu, J. (2025) · BMC Medical Imaging · doi:10.1186/s12880-025-01729-7 · Cited by 9 · see citing works

Ribosomal S6 protein kinase 4 promotes resistance to EZH2 inhibitors in glioblastoma

Pang, F., Zhang, L., Li, M., Yi, X., Wang, Y., Yang, P., Wen, B., Jiang, J., Teng, Y., Yang, X., et al. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00666-3 · Cited by 9 · see citing works

Molecular Profiling and Targeted Therapies in Gliomas

Felistia, Y., & Wen, P. Y. (2023) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-023-01299-7 · Cited by 9 · see citing works

Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group

Mueller, S., Fangusaro, J., Thomas, A. O., Jacques, T. S., Bandopadhayay, P., de Blank, P. M. K., Packer, R. J., Fouladi, M., Meeteren, A. Y. N. S., Jones, D., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad227 · Cited by 9 · see citing works

Neurosurgical application of olaparib from a thermo-responsive paste potentiates DNA damage to prolong survival in malignant glioma

Serra, R., Smith, S. J., Rowlinson, J., Gorelick, N. L., Moloney, C., McCrorie, P., Veal, G. J., Berry, P., Chalmers, A. J., Suk, I., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02878-2 · Cited by 10 · see citing works

Low-intensity ultrasound: A novel technique for adjuvant treatment of gliomas

Fang, Y. R., Zhang, G., Bai, Z., Yan, Y., Song, X., Zhao, X., Yang, P., & Zhang, Z. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113394 · Cited by 9 · see citing works

Structural Prediction and Characterization of Canavalia grandiflora (ConGF) Lectin Complexed with MMP1: Unveiling the Antiglioma Potential of Legume Lectins

Leal, R. B., Mann, J., Pinto‐Junior, V. R., Oliveira, M. V., Osterne, V. J. S., Wolin, I. A. V., Nascimento, A. P. M., Welter, P. G., Ferreira, V. M. S., Silva, A. A., et al. (2022) · Molecules · doi:10.3390/molecules27207089 · Cited by 9 · see citing works

The value of multiparametric MRI radiomics in predicting IDH genotype in glioma before surgery

Liang, Y., Liu, W., Bai, D., Hu, J., & Wang, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1265672 · Cited by 8 · see citing works

Pyrosequencing Analysis of O-6-Methylguanine-DNA Methyltransferase Methylation at Different Cut-Offs of Positivity Associated with Treatment Response and Disease-Specific Survival in Isocitrate Dehydrogenase-Wildtype Grade 4 Glioblastoma

Silva, F. F. V. E., Domenico, M. D., Caponio, V. C. A., Pérez‐Sayáns, M., Camolesi, G. C. V., Rojo-Álvarez, L. I., Ballini, A., Garcı́a, A. G., Padín-Iruegas, E., & Peñaranda, J. M. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010612 · Cited by 8 · see citing works

Performance Comparison of Diffusion Kurtosis Imaging (DKI), Neurite Orientation Dispersion and Density Imaging (NODDI), and Diffusion Microstructure Imaging (DMI) in Predicting Adult-Type Glioma Subtype—A Pilot Study

Zerweck, L., Würtemberger, U., Klose, U., Reisert, M., Richter, V., Nägele, T., Staber, D., Han, T., Shen, M., Xie, C., et al. (2025) · Cancers · doi:10.3390/cancers17050876 · Cited by 8 · see citing works

Comparison of Fluorescence In Situ Hybridization, Next-Generation Sequencing, and DNA Methylation Microarray for Copy Number Variation Assessment in Gliomas

Wang, J., Yang, L., Qi, H.-Y., Wang, L., Wei, S., Yuan, Y., Ge, J., Li, A., Yan, Z., Li, L. M., et al. (2025) · Laboratory Investigation · doi:10.1016/j.labinv.2025.104168 · Cited by 8 · see citing works

EphB2-Targeting Monoclonal Antibodies Exerted Antitumor Activities in Triple-Negative Breast Cancer and Lung Mesothelioma Xenograft Models

Ubukata, R., Ohishi, T., Kaneko, M. K., Suzuki, H., & Kato, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178302 · Cited by 8 · see citing works

An online survival predictor in glioma patients using machine learning based on WHO CNS5 data

Ye, L., Gu, L., Zheng, Z., Zhang, X., Xing, H., Guo, X., Chen, W., Wang, Y., Wang, Y., Liang, T., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1179761 · Cited by 8 · see citing works

Preclinical and Clinical Use of Indigenously Developed 99mTc-Diethylenetriaminepentaacetic Acid-Bis-Methionine: l -Type Amino Acid Transporter 1-Targeted Single Photon Emission Computed Tomography Radiotracer for Glioma Management

Hazari, P. P., Yadav, S. K., Kumar, P., Dhingra, V., Rani, N., Kumar, R., Singh, B., & Mishra, A. K. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00091 · Cited by 8 · see citing works

Establishment of a Prediction Model Based on Preoperative MRI Radiomics for Diffuse Astrocytic Glioma, IDH-Wildtype, with Molecular Features of Glioblastoma

Du, P., Wu, X., Liu, X., Chen, J., Cao, A., & Geng, D. (2023) · Cancers · doi:10.3390/cancers15205094 · Cited by 8 · see citing works

EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266–283 antitumor response in preclinical glioblastoma models

Álvarez-Vázquez, A., San‐Segundo, L., Cerveró-García, P., Flores-Hernández, R., Ollauri-Ibáñez, C., Segura‐Collar, B., Hubert, C. G., Morrison, G. M., Pollard, S. M., Lathia, J. D., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae060 · Cited by 8 · see citing works

LINC00606 promotes glioblastoma progression through sponge miR-486-3p and interaction with ATP11B

Dong, N., Qi, W., Wu, L., Li, J., Zhang, X., Wu, H., Zhang, W., Jiang, J., Zhang, S., Fu, W., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03058-z · Cited by 8 · see citing works

Major Features of the 2021 WHO Classification of CNS Tumors

Smith, H. L., Wadhwani, N. R., & Horbinski, C. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01249-0 · Cited by 108 · see citing works

The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021

Perez, A., & Huse, J. T. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01153-8 · Cited by 68 · see citing works

Neuro-oncology, 2021. Brief analysis of the new World Health Organization classification of tumors of the central nervous system

Мацко, М. В., & Мацко, Е. Д. (2022) · Vestnik of Saint Petersburg University Medicine · doi:10.21638/spbu11.2022.202 · Cited by 5 · see citing works

Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system

Gritsch, S., Batchelor, T. T., & Castro, L. N. G. (2021) · Cancer · doi:10.1002/cncr.33918 · Cited by 380 · see citing works

2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review

Thomas, D. (2023) · Chinese Clinical Oncology · doi:10.21037/cco-22-120 · Cited by 90 · see citing works